🔎 Trials Near Me

Gara Jalqabaatti › Saree Oljoo › Texas › Austin

Qorannoo klinikaalii Saree Oljoo Austin, TX keessatti

Qorannoo 18 Saree Oljoo f Austin fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Texas Oncology Central/South, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06982521

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Namoota walitti qabaa jiraSadarkaa 1/2
  • New Experimental Therapeutics - NEXT Oncology, Austin
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04585750

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Next Oncology Austin, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07222267

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Namoota walitti qabaa jiraSadarkaa 1
  • NEXT Oncology - Austin, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06253871

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Texas Oncology, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07287917

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • NEXT Austin, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT07383506

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Namoota walitti qabaa jiraSadarkaa 3
  • Texas Oncology - Austin, Austin
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT05232916

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Texas Oncology - Central / South Texas, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT05579366

Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer

Namoota walitti qabaa jiraSadarkaa 1/2
  • Texas Oncology - Central/South, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ado-2026 · NCT07558733

Cancer Pain Management Using a Web-based Intervention

Namoota walitti qabaa jira
  • The University of Texas at Austin, Austin
Umuriin 18 fi ol · Dubartoota · Haaromfame 09-Wax-2026 · NCT06085313

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Namoota walitti qabaa jiraSadarkaa 3
  • Texas Oncology - Central South (Balcones Dr), Austin
  • Texas Oncology - Central South (James Casey), Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Cam-2026 · NCT07062965

Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • NEXT Oncology Austin, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Elb-2026 · NCT07424547

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Elligo Health Research, Inc., Austin
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 20-Ama-2026 · NCT05366881

Sample Collection for Ongoing Research and Product Evaluation Study

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Natera, Inc., Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ama-2026 · NCT07318051

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Exelixis Clinical Site #4, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Ful-2025 · NCT05932862

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Texas Oncology - Austin, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2025 · NCT03053193

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • Texas Oncology PA (Austin), Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Wax-2025 · NCT06568692

Qorannoo Saree Oljoo magaalota biroo keessatti

Qorannoo biroo Austin keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.